Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...
SAN FRANCISCO, September 29, 2025 — A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low ...
MedPage Today on MSN
Proton Therapy for Oropharyngeal Cancer Makes a Case for Standard of Care
Proton radiotherapy (RT) for oropharyngeal cancer matched conventional photon therapy for slowing disease progression and led ...
For patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) is noninferior to intensity ...
Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In patients with ...
Cervical squamous cell carcinoma of the esophagus-a unique series of limited resection and free jejunal graft interposition after neoadjuvant RCTx in 94 patients This is an ASCO Meeting Abstract from ...
Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...
USA: A large US-based phase III clinical trial has shown that proton radiotherapy offers a meaningful survival advantage and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results